ALEXANDRIA SKYRUD: Open Payments
NPI 1497591408 · PARK RIVER, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $156 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 6 | $118 |
| Neurocrine BioSciences, Inc. | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Verona Pharma, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| KYOWA KIRIN, INC. | 1 | $16 |
Products named: VOQUEZNA, INGREZZA, CAPLYTA, Ohtuvayre, OTEZLA, LILETTA, Veozah, ZEPBOUND.
Industry payments across ND — which companies pay providers there.
